A 1439New Jersey
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
In committee
Jan 9, 2024: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee